# How gut microbiota contribute to neuropsychiatric disorders: evidence from neuroimaging studies

**Authors:** Chunlan Jia, Wenjie Zhu, Yanling Yuan, Qinglian Xie

PMC · DOI: 10.3389/fmicb.2026.1760096 · Frontiers in Microbiology · 2026-03-04

## TL;DR

This paper reviews how gut microbes affect brain disorders by using imaging to show their impact on brain structure and function.

## Contribution

It introduces a neuroimaging-driven framework to study gut-brain interactions, moving beyond general mechanisms.

## Key findings

- Gut microbiota influence brain disorders via the microbiota-gut-brain axis, affecting structure and function.
- Neuroimaging reveals microbial associations with conditions like Alzheimer’s and schizophrenia.
- Microbial metabolites and immune responses mediate these effects, suggesting new clinical applications.

## Abstract

The interaction between the gut microbiota and central nervous system (CNS) diseases has emerged as a major focus in neuroscience and microbiome research. Accumulating evidence shows that gut microbiota influence the pathogenesis of neurodevelopmental, neurodegenerative, autoimmune, and psychiatric conditions via the microbiota-gut-brain axis. However, the underlying mechanisms are complex and not yet fully elucidated. Advances in multimodal magnetic resonance imaging, positron emission tomography, and diffusion tensor imaging, now enable in vivo visualization of associations between gut microbial alterations and abnormalities in brain structure and function, providing new perspectives for understanding the role of gut microbiota in CNS pathology. This review systematically reviews neuroimaging-based research linking gut microbiota to neurological diseases (e.g., Alzheimer’s disease, multiple sclerosis, traumatic brain injury), and psychiatric disorders (e.g., schizophrenia, and autism spectrum disorder). It highlights the mediating roles of microbial metabolites, immune-inflammatory responses, and neuroimmune pathways, and discusses future directions integrating multi-omics data with neuroimaging technologies, as well as their potential clinical applications. What distinguishes this review from its predecessors in the same field is its explicit neuroimaging-driven framework rather than general mechanistic discussion.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975), multiple sclerosis (MONDO:0005301), traumatic brain injury (MONDO:0858950), schizophrenia (MONDO:0005090), autism spectrum disorder (MONDO:0005258)

## Full-text entities

- **Diseases:** autism spectrum disorder (MESH:D000067877), multiple sclerosis (MESH:D009103), abnormalities in brain (MESH:D001927), Alzheimer's disease (MESH:D000544), inflammatory (MESH:D007249), traumatic brain injury (MESH:D000070642), schizophrenia (MESH:D012559), autoimmune, and psychiatric conditions (MESH:D001523), system (CNS) diseases (MESH:D002493), neurological diseases (MESH:D020271)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996146/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12996146/full.md

## References

183 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996146/full.md

---
Source: https://tomesphere.com/paper/PMC12996146